$1.82
0.116.43%
At Close: -
$1.82
0.00150.08%
After Hours: Sep 20, 5:49 PM EDT
15 minutes delayed
Comments
Loading...
Regulus Therapeutics (NASDAQ:RGLS) Stock, Earnings Estimates, EPS, And Revenue
Regulus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 7
EPS Estimate
$-0.170
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Regulus Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Regulus Therapeutics (RGLS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $-0.17 | $-0.13 | -30.8 % |
| Mar 2024 | 2024-05-09 | $-0.29 | $-0.21 | -38.1 % |
| Dec 2023 | 2024-03-21 | $-0.40 | $-0.39 | -2.56 % |
| Sep 2023 | 2023-11-09 | $-0.40 | $-0.40 | 0.00 % |
Regulus Therapeutics (RGLS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2021 | 2021-08-10 | $0 | $10.00K | -100.0 % |
| Mar 2021 | 2021-05-13 | $0 | $20.00K | -100.0 % |
| Sep 2020 | 2020-11-05 | $5.00M | $340.00K | 1370.6 % |
FAQ
When is Regulus Therapeutics (NASDAQ:RGLS) reporting earnings?
Regulus Therapeutics (RGLS) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
What were the latest earnings per share (EPS) for Regulus Therapeutics (NASDAQ:RGLS)?
The Actual EPS was $-0.17, which missed the estimate of $-0.13.
What were Regulus Therapeutics’s (NASDAQ:RGLS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.